Erlocip (Erlotinib) is a type of targeted therapy used to treat cancer. Erlotinib is a tyrosine kinase inhibitor that works by blocking the kinase activity of a protein called epidermal growth factor receptor (EGFR), which is involved in cell growth and survival.
Reviews
There are no reviews yet.